Prime-boost, double-dose influenza vaccine immunity in COPD: a pilot observational study.

Gary P AndersonLouis B IrvingAndrew G JarnickiKatherine KedzierskaMarios KoutsakosStephen KentAeron C HurtAdam K WheatleyThi H O NguyenNatale SnapeJohn W Upham

Published in: ERJ open research (2023)

Prime-boost, double-dose immunisation does not further improve influenza vaccine immunogenicity in previously vaccinated COPD patients. These findings underscore the need to design more effective vaccine strategies for COPD patients for influenza.

Keyphrases

end stage renal disease
chronic obstructive pulmonary disease
ejection fraction
newly diagnosed
chronic kidney disease
lung function
prognostic factors
clinical trial
patient reported outcomes
air pollution